FEATURE ARTICLES
The FDA has finalized a guidance on the circumstances that constitute delaying, denying, limiting, or refusing a drug or device inspection. The agency also provides reasons that may cause drugs or devices to be adulterated under the FD&C Act.
- Making Good Decisions When FDA Investigators Come Knocking
- 5 Recommendations To Maximize CSV/CSA Outcomes
- How Eli Lilly's Making Peptides Faster And More Reliably
- Bacterial Endotoxin Testing, Part 1: Overview
- Correct But Misleading: AI Hallucinations In Complex Decision-Making
- Why Knowledge Workers Must Embrace Standard Work
- ChatGPT-4: Practical Applications For The Biopharma Laboratory
PHARMA ONLINE WHITE PAPERS
-
Eliminating USP <88> In Vivo Animal Bioreactivity Testing For Polymer Characterization
There has been growing awareness about the environmental and ethical implications of plastics used in bioprocessing. The time for a shift to well-studied, proven in vitro cytotoxicity testing is now.
-
Five Of The Most Useful Transformations In Modern Organic Synthesis8/3/2023
The five reactions commonly used in medicinal chemistry are a mix of “traditional” reactions and newer transformations that all share a high level of robustness and flexibility.
-
Building A Compelling Business Case For Quality Transformation2/26/2024
Discover the key to a successful quality transformation, explore the business value of modern quality systems, and learn how quality leaders can build a compelling case for change.
-
The Key To Accelerating RNA-LNP Drug Development12/27/2023
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
Intro To USP <1062> - What It Is And Why You Should Use It7/20/2023
Knowing how to use USP <1062> helps manufacturers manage the wide variety of factors that can exacerbate production costs, or result in no product at all.
-
Revolutionizing Manufacturing For Pharma And Biopharma7/9/2024
Explore the evolution of Industry 4.0 in pharmaceutical manufacturing, the benefits and implications of Smart Factories, and the challenges along the road toward implementing a Smart Factory.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Exosome Isolation By TFF And Size Exclusion Chromatography
- Reagents For Highly Efficient T Cell Manufacturing
- Sterility Testing Of Products With Antimicrobial Properties
- Improving Manufacturing Data Collection And Information Visibility
- Chromatography Column Qualification And Protein Purification Demonstration
NEWSLETTER ARCHIVE
- 07.26.24 -- How Eli Lilly's Making Peptides Faster And More Reliably
- 07.25.24 -- Life Cycle Planning For Drug Product Containment And Delivery
- 07.25.24 -- 5 Recommendations To Maximize CSV/CSA Outcomes
- 07.24.24 -- Implementing Optimal Quality Standards To Enhance Development And Manufacturing Process Performance
- 07.23.24 -- Getting The CAPA Framework Right The First Time
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content Collections